237 related articles for article (PubMed ID: 38697464)
1. Investigating Resistance to Antidepressants in Animal Models.
Peña JE; Corbett BF; Tamminga CA; Bhatnagar S; Hitti FL
Neuroscience; 2024 Jun; 548():69-80. PubMed ID: 38697464
[TBL] [Abstract][Full Text] [Related]
2. The Wistar-Kyoto rat model of endogenous depression: A tool for exploring treatment resistance with an urgent need to focus on sex differences.
Millard SJ; Weston-Green K; Newell KA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109908. PubMed ID: 32145362
[TBL] [Abstract][Full Text] [Related]
3. The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression.
Meylan EM; Halfon O; Magistretti PJ; Cardinaux JR
Neuropharmacology; 2016 Aug; 107():111-121. PubMed ID: 26970016
[TBL] [Abstract][Full Text] [Related]
4. Understanding the genetic aspects of resistance to antidepressants treatment.
Alqahtani AM; Kumarappan C; Kumar V; Srinivasan R; Krishnaraju V
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7784-7795. PubMed ID: 32744705
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of esketamine in resistant major depressive disorder: A systematic review of the literature].
Mungo A; Hein M
Encephale; 2022 Aug; 48(4):455-461. PubMed ID: 35221019
[TBL] [Abstract][Full Text] [Related]
6. The forced swim test has poor accuracy for identifying novel antidepressants.
Trunnell ER; Carvalho C
Drug Discov Today; 2021 Dec; 26(12):2898-2904. PubMed ID: 34390862
[TBL] [Abstract][Full Text] [Related]
7. Preclinical models of treatment-resistant depression: challenges and perspectives.
Kolasa M; Faron-Górecka A
Pharmacol Rep; 2023 Dec; 75(6):1326-1340. PubMed ID: 37882914
[TBL] [Abstract][Full Text] [Related]
8. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature of antidepressant treatment response/non-response in Flinders Sensitive Line rats subjected to maternal separation.
Marchetti L; Lauria M; Caberlotto L; Musazzi L; Popoli M; Mathé AA; Domenici E; Carboni L
Eur Neuropsychopharmacol; 2020 Feb; 31():69-85. PubMed ID: 31813757
[TBL] [Abstract][Full Text] [Related]
10. Treatment-resistant depression: are animal models of depression fit for purpose?
Willner P; Belzung C
Psychopharmacology (Berl); 2015 Oct; 232(19):3473-95. PubMed ID: 26289353
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Prelimbic Stimulation Ameliorates Depressive-Like Behaviors and Increases Regional BDNF Expression in a Novel Drug-Resistant Animal Model of Depression.
Moshe H; Gal R; Barnea-Ygael N; Gulevsky T; Alyagon U; Zangen A
Brain Stimul; 2016; 9(2):243-50. PubMed ID: 26655599
[TBL] [Abstract][Full Text] [Related]
13. Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies.
De Risio L; Borgi M; Pettorruso M; Miuli A; Ottomana AM; Sociali A; Martinotti G; Nicolò G; Macrì S; di Giannantonio M; Zoratto F
Transl Psychiatry; 2020 Nov; 10(1):393. PubMed ID: 33173042
[TBL] [Abstract][Full Text] [Related]
14. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
[TBL] [Abstract][Full Text] [Related]
15. Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression.
Pereira VS; Joca SRL; Harvey BH; Elfving B; Wegener G
Acta Neuropsychiatr; 2019 Oct; 31(5):258-265. PubMed ID: 31230597
[TBL] [Abstract][Full Text] [Related]
16. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
Abdallah CG; Sanacora G; Duman RS; Krystal JH
Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
[TBL] [Abstract][Full Text] [Related]
17. Rodent models of treatment-resistant depression.
Caldarone BJ; Zachariou V; King SL
Eur J Pharmacol; 2015 Apr; 753():51-65. PubMed ID: 25460020
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the adrenocorticotrophic hormone - induced mouse model of resistance to antidepressant drug treatment.
Srikumar BN; Paschapur M; Kalidindi N; Adepu B; Das ML; Sreedhara MV; Kuchibhotla VK; Pieschl RL; Li YW; Ega DSP; Louis JV; Murugesan S; Naidu PS; Ramarao M; Bristow LJ; Vikramadithyan RK
Pharmacol Biochem Behav; 2017 Oct; 161():53-61. PubMed ID: 28911960
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.
Chang CM; Sato S; Han C
CNS Drugs; 2013 May; 27 Suppl 1():S21-7. PubMed ID: 23712796
[TBL] [Abstract][Full Text] [Related]
20. Faster, better, stronger: towards new antidepressant therapeutic strategies.
O'Leary OF; Dinan TG; Cryan JF
Eur J Pharmacol; 2015 Apr; 753():32-50. PubMed ID: 25092200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
